tiprankstipranks
Indaptus Therapeutics (INDP)
NASDAQ:INDP
US Market

Indaptus Therapeutics (INDP) Financial Statements

464 Followers

Indaptus Therapeutics Financial Overview

Indaptus Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.835; its P/E ratio is -1.36; Indaptus Therapeutics is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue---$ -110.00K$ 0.00
Gross Profit---$ -110.00K-
EBIT$ -3.92M$ -3.25M$ 4.53M$ -4.19M$ -3.55M
EBITDA$ -3.92M$ -3.24M$ 4.53M$ -4.19M$ -3.55M
Net Income Common Stockholders$ -3.92M$ -3.25M$ 4.53M$ -3.76M$ -3.47M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 15.96M$ 19.69M$ 21.68M$ 26.43M$ 28.46M
Total Assets$ 17.79M$ 20.84M$ 23.14M$ 28.06M$ 30.45M
Total Debt$ 196.24K$ 216.59K$ 236.51K$ 80.49K$ 103.57K
Net Debt$ -15.77M$ -19.48M$ -21.44M$ -26.35M$ -28.36M
Total Liabilities$ 2.46M$ 2.22M$ 1.96M$ 3.43M$ 2.89M
Stockholders Equity$ 15.33M$ 18.62M$ 21.23M$ 24.63M$ 27.57M
Cash Flow-
Free Cash Flow$ -3.73M$ -2.11M$ -4.96M$ -2.21M$ -4.60M
Operating Cash Flow$ -3.73M$ -2.11M$ -4.96M$ -2.21M$ -4.60M
Investing Cash Flow$ 7.00M$ 8.00M$ 2.14M$ 5.12M$ -2.94M
Financing Cash Flow----$ 0.00
Currency in USD

Indaptus Therapeutics Earnings and Revenue History

Indaptus Therapeutics Debt to Assets

Indaptus Therapeutics Cash Flow

Indaptus Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis